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ABSTRACT
Carcinoid tumours are  rare  neuroendocrine tumours causing  a  spectrum  of  symptoms  ranging  from  chronic
intestinal obstruction to systemic symptoms like sweating, diarrhoea and right side heart failure. We present here
the case history of a male patient aged forty with a carcinoid tumour in the distal small intestine presenting with
chronic intermittent intestinal obstruction and no systemic symptoms and metastasis. This case is presented for its
rarity.
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INTRODUCTION
The carcinoid tumors are well differentiated tumors
of  the  neuroendocrine  cells.
1Though  rare, these
tumorsare mostly found in the terminal ileum.
1,2They
are  also  the  most  common  tumor  of  the
appendix.
1Those  that  are  found  in  the jejunum  and
ileum are multicentric in 26-30% of the cases
2. As
metastasis from these tumours are late, mostpatients’
presents with hepatic metastasis.
3
CASE REPORT
A male patient aged  forty  presented  to  us at
Meenakshi  Medical  College  Hospital  &  Research
Institute,  Kanchipuram with  complaints of  lower
abdominal pain with episodes of vomiting and nausea
and  a mass in  the  right  iliac  fossa.The  patient  had
repeated  episodes  of  vomiting  and  intermittent
abdominal pain with the appearance - disappearance
of the abdominal mass over a period of three months
before presenting  to  us. Primary examination
revealed a right iliac fossa mass with visible intestinal
peristalsis  and  active  bowel  sounds. The  patient
underwent  a sonography,  which showed  peristaltic
dilated jejunal and ileal bowel loops. An abdominal
CT was done, which identified the same and rolled up
thickened mesentery.  A  provisional  diagnosis  of
ileocecal  tuberculosis  abdomen  was  made  and  the
patient  was  managed  initially  by  nil  per oral,
intravenous fluids  and  antibiotics  and Ryle’s tube
aspiration. The  patient  underwent  an  emergency
laparotomy  when  the  abdomen  was  silent  and
abdominal  X-ray  showed  features  of  intestinal
obstruction.
During laparotomy,  we found  the presence  of
unhealthy  thickened  fibrotic  and  bunched  together
loops  of  small  bowel about  twenty centimeters
proximal to the ileocecal junction. The mesentery was
thickened and rolled up and a few lymph nodeswere
also found in the mesentery. The team resected the
unhealthy  bowel  and  performed  an  end  to  end
anastomosis. Histopathology revealed a small bowel
carcinoid(Fig 1) with  clear  margins  with  no
mesenteric  nodal  metastasis. The  post  operative
period of the patient was devoid of complications and
an evaluation for metastasis was done by estimation
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of  5-HIAA  in  24  hour  urinary  sample  which was
negative.
Fig  1:  Histopathology  of  carcinoid  tumour  showing
cells arranged in clusters.
DISCUSSION
Oberndorfer coined  the  term  carcinoid  in  1907  to
describe ‘hormonally active tumors’.
4 They originate
from  the  gut  wall  stem  cells  and  are  classified
depending on the location.
5 They constitute more than
two  thirds  of  all  carcinoids and  1.5%  of  all  GI
tumors.8.4% are found at autopsies.
6 Various sites of
origin  of  this neoplasm  are extra  gastrointestinal
33%,small  intestine  30%,rectum  11%  ,colon
10%,appendix  8%,stomach  4-8%,  duodenum/
pancreas  <  2%, esophagus  <1%.
6 The  tumors  are
often  diagnosed late  as most tumors  are
silent.
7Clinical presentation  ranges from  obstructive
symptoms, secondary to small bowel obstruction due
to  peritumoral  fibrosis  or  desmoplastic  reactions
leading to ischemic changes, to vasoactive symptoms
of  a  functioning  tumor  like  secretory diarrhoea,
cutaneous flushing and heart valve fibrosis.
8
The  term  'carcinoid  tumor' reserved  for  classical
midgut carcinoid secreting serotonin.
9The syndrome
occurs due  to vasoactive in  the systemic
circulation.The  demonstration  of  rising
concentrations of 5-HIAA in 24 hour urine samples
biochemically diagnoses carcinoidtumour.    The
primary midgut carcinoids are generally too small to
be  diagnosed  with  conventional  contrast
studies.
10,11The  presence  of    a  circumscribed
mesenteric mass with radiating densities in CT is very
suspicious  of  a  midgut  carcinoid  mesenteric
metastasis.
11Segmental  occlusions  and tortuosity of
mesenteric  vessels are  seen  in  mesenteric
angiography.
11The presence of hepatic metastases is
detected by Ultrasonography. PET with the serotonin
precursor  5-hydroxytryptophan labeled with  C
11 are
highly  sensitive  in  identifying small  bowel
carcinoids.
12
Surgical resection remains the primary management
of carcinoid tumours.Lesions less than 1 cm requires
local resection, but lesions more than 1.5 cm requires
extensivesegmental resection owing to its high risk of
recurrence.
1 Surgery proves  beneficial  in
symptomatic relief, prevention  of  metastasis  and
improves  the  prognosis.
3Somatostatin  analogues  are
proven not only to be useful in relieving the patients
of symptoms secondary to amines in the circulation in
70-80%  of  patients,  but  also  stabilizes the tumour
growth.
3
There  has  been  a  significant  change  in  the
management  of  carcinoid tumours with  hepatic
metastases. A 90% symptomatic relief was reported
by Que et al. with liver resection.
13However, studies
have  shown  similar benefits  using  Hepatic
ArteryEmbolization as an alternative to surgery.
14
CONCLUSION
Carcinoid tumours are rare and have a good prognosis
if  treated  early.  Often  they  are  diagnosed
postoperatively by the pathologist. Hence a suspicion
of a carcinoid tumour is a must in the evaluation of a
patient  with  chronic  intermittent  intestinal
obstruction. A thorough surveillance of the abdomen
per operatively for mesenteric lymph nodal metastasis
and  a  regular  postoperative  biochemical  follow  up
with 24 hour urinary 5-HIAA improves the survival
of the patient.
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